Cargando…
Immune response and possible therapeutics in COVID-19
COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop ther...
Autores principales: | Dutta, Anindya, Roy, Ananya, Roy, Laboni, Chattopadhyay, Samit, Chatterjee, Subhrangsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693424/ https://www.ncbi.nlm.nih.gov/pubmed/35423713 http://dx.doi.org/10.1039/d0ra08901j |
Ejemplares similares
-
Peptide therapeutics in the management of metastatic cancers
por: Bose, Debopriya, et al.
Publicado: (2022) -
Site-specific amino acid substitution in dodecameric peptides determines the stability and unfolding of c-MYC quadruplex promoting apoptosis in cancer cells
por: Sengupta, Pallabi, et al.
Publicado: (2018) -
De Novo designed 13 mer hairpin-peptide arrests insulin and inhibits its aggregation: role of OH–π interactions between water and hydrophobic amino acids
por: Mukherjee, Meghomukta, et al.
Publicado: (2020) -
Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters
por: Roy Chattopadhyay, Nabanita, et al.
Publicado: (2020) -
Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach
por: Das, Ananya, et al.
Publicado: (2021)